Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Meiosis II

Meiosis II

Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each...

Oogenesis

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...

Oogenesis

Oogenesis

Oogenesis, the process of developing egg cells (female gametes), occurs within the ovaries and is fundamental to female fertility. This sequence begins during fetal development when diploid oogonia in the developing ovaries undergo mitotic divisions to produce primary oocytes. By birth, these primary oocytes enter prophase I of meiosis but become arrested in this stage, remaining suspended until puberty.
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Should we routinely perform sperm DNA fragmentation testing in fertility clinics?

Human reproduction open·2026

Same author

Removal of small fibroids and polyps in patients with infertility and recurrent miscarriage: The HELP Fertility? RCT.

Health technology assessment (Winchester, England)·2026

Same author

Value of sperm DNA fragmentation (SDF) in predicting reproductive outcomes - a systematic review and meta-analysis.

Human fertility (Cambridge, England)·2026

Same author

The integration of artificial intelligence in assisted reproduction: a comprehensive review.

Frontiers in reproductive health·2025

Same author

Upconversion nanoparticle-based optical biosensor for early diagnosis of stroke.

Biosensors & bioelectronics·2025

Same author

The impact of age and number of oocytes retrieved on the cumulative live birth rate in women with poor ovarian response: A 15-year study.

European journal of obstetrics, gynecology, and reproductive biology·2024

Search research articles

Related Experiment Video

Updated: Nov 4, 2025

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

Current perspectives on social oocyte freezing.

Ung Lim Teo¹, Pragati Kakkar², Tarek El-Toukhy³

¹Women's Services, Epsom and St Helier University Hospitals NHS Trust, London, UK.

Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology

|May 24, 2021

Summary

Social oocyte freezing is increasingly popular for women delaying childbirth. However, the optimal age is below 35, with significant costs and a 18% live birth rate per thaw cycle.

Keywords:

IVF Social egg freezing elective oocyte cryopreservation live birth pregnancy vitrification

More Related Videos

Author Spotlight: Advancing Fertility Preservation in Young Female Cancer Patients Through Ovarian Tissue Vitrification and In Vitro Follicular Growth

Author Spotlight: Advancing Fertility Preservation in Young Female Cancer Patients Through Ovarian Tissue Vitrification and In Vitro Follicular Growth

Published on: August 9, 2024

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

Related Experiment Videos

Last Updated: Nov 4, 2025

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

Author Spotlight: Advancing Fertility Preservation in Young Female Cancer Patients Through Ovarian Tissue Vitrification and In Vitro Follicular Growth

Author Spotlight: Advancing Fertility Preservation in Young Female Cancer Patients Through Ovarian Tissue Vitrification and In Vitro Follicular Growth

Published on: August 9, 2024

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

Area of Science:

Reproductive Science
Social Science

Background:

Growing demand for elective oocyte cryopreservation (egg freezing) among women delaying childbirth.
Societal trends indicate delayed parenthood and a desire to extend reproductive timelines.

Purpose of the Study:

To analyze the current trends, efficacy, and implications of social oocyte freezing.
To inform women considering elective egg freezing about crucial factors influencing reproductive choices.

Main Methods:

Review of current practices and statistics related to social oocyte freezing.
Analysis of age demographics, relationship status, and treatment costs.
Evaluation of live birth rates per oocyte thaw cycle and influencing factors.

Main Results:

The mean age of women undergoing oocyte freezing in the UK is 38, exceeding the optimal age of <35.
Approximately 50% of women undergoing this procedure are not in a relationship.
The average cost exceeds £7000, with an 18% live birth rate per thaw cycle, varying by age at freezing.

Conclusions:

Comprehensive counseling is essential for women considering social oocyte freezing.
Informed decision-making requires thorough understanding of efficacy, limitations, and financial implications.
Support systems are crucial for enabling informed reproductive choices regarding elective egg freezing.